Skip to content

Insider · CIK 0001745958

Jerel Davis

Reports to the SEC for 4 companies · LOS ANGELES, CA

Transactions

50

Companies

4

Filings

5

CIK

0001745958

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2025-08-08Turnstone Biologics Corp.U Disposition from Tender—
2025-08-08Turnstone Biologics Corp.U Disposition from Tender—
2025-08-08Turnstone Biologics Corp.U Disposition from Tender—
2025-08-08Turnstone Biologics Corp.U Disposition from Tender—
2025-08-08Turnstone Biologics Corp.U Disposition from Tender—
2024-06-03Turnstone Biologics Corp.Stock Option (Right to Buy)A Award—
2023-10-16Turnstone Biologics Corp.Stock Option (Right to Buy)A Award—
2023-08-11CHINOOK THERAPEUTICS, INC.D Disposition to Issuer—
2023-08-11CHINOOK THERAPEUTICS, INC.D Disposition to Issuer—
2023-08-11CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer−$138K
2023-08-11CHINOOK THERAPEUTICS, INC.D Disposition to Issuer—
2023-08-11CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer−$347K
2023-08-11CHINOOK THERAPEUTICS, INC.Stock Option (Right to Buy)D Disposition to Issuer−$593K
2023-08-11CHINOOK THERAPEUTICS, INC.D Disposition to Issuer—
2023-07-25Turnstone Biologics Corp.Series B-1 Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.P Purchase+$2.37M
2023-07-25Turnstone Biologics Corp.P Purchase+$71.3K
2023-07-25Turnstone Biologics Corp.Series A Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series C Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.C Conversion—
2023-07-25Turnstone Biologics Corp.Series A Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series C Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series A Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series C Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series C Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series D Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series B-2 Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series A Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series B-2 Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.C Conversion—
2023-07-25Turnstone Biologics Corp.C Conversion—
2023-07-25Turnstone Biologics Corp.Series B-2 Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series B-2 Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.Series B-1 Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.P Purchase+$78.9K
2023-07-25Turnstone Biologics Corp.Series B-1 Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.C Conversion—
2023-07-25Turnstone Biologics Corp.P Purchase+$180K
2023-07-25Turnstone Biologics Corp.Series B-1 Preferred StockC Conversion—
2023-07-25Turnstone Biologics Corp.C Conversion—
2023-07-19LENZLENZ Therapeutics, Inc. · Stock Option (right to buy)A Award—
2023-05-26CHINOOK THERAPEUTICS, INC.Restricted Stock UnitsM Exercise/Conversion—
2023-05-26CHINOOK THERAPEUTICS, INC.M Exercise/Conversion—
2023-04-17CHINOOK THERAPEUTICS, INC.S Sale−$6.14M
2023-03-01CHINOOK THERAPEUTICS, INC.S Sale−$5.46M
2023-03-01CHINOOK THERAPEUTICS, INC.S Sale−$2.8M
2023-03-01CHINOOK THERAPEUTICS, INC.S Sale−$836K
2022-12-29RPTXRepare Therapeutics Inc.J Other—
2022-12-29RPTXRepare Therapeutics Inc.J Other—
2022-12-29RPTXRepare Therapeutics Inc.J Other—

Recent filings

5

Companies

4

Address

C/O TURNSTONE BIOLOGICS CORP. 1110 NORTH VIRGIL AVENUE PMB 94659

LOS ANGELES, CA, 90029